{"id":"https://openalex.org/W4363672583","doi":"https://doi.org/10.1002/prp2.1083","title":"Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID\u201019","display_name":"Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID\u201019","publication_year":2023,"publication_date":"2023-04-01","ids":{"openalex":"https://openalex.org/W4363672583","doi":"https://doi.org/10.1002/prp2.1083","pmid":"https://pubmed.ncbi.nlm.nih.gov/37038324","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10086312"},"language":"en","primary_location":{"id":"doi:10.1002/prp2.1083","doi":"https://doi.org/10.1002/prp2.1083","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.1083","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.1083","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.1083","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044696774","display_name":"Rodolfo Pedro Rothlin","orcid":"https://orcid.org/0000-0003-4731-6099","observed_orcids":["https://orcid.org/0000-0003-4731-6099"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rodolfo Pedro Rothlin","raw_affiliation_strings":["Sociedad Argentina de Farmacolog\u00eda Cl\u00ednica, Asociaci\u00f3n M\u00e9dica Argentina  Buenos Aires Argentina"],"raw_orcid":"https://orcid.org/0000-0003-4731-6099","affiliations":[{"raw_affiliation_string":"Sociedad Argentina de Farmacolog\u00eda Cl\u00ednica, Asociaci\u00f3n M\u00e9dica Argentina  Buenos Aires Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030352508","display_name":"Facundo Germ\u00e1n Pelorosso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Facundo Germ\u00e1n Pelorosso","raw_affiliation_strings":["Servicio de Anatom\u00eda Patol\u00f3gica Hospital de Alta Complejidad El Calafate SAMIC  Santa Cruz Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Anatom\u00eda Patol\u00f3gica Hospital de Alta Complejidad El Calafate SAMIC  Santa Cruz Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113543237","display_name":"Mariano Duarte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24354313","display_name":"Universidad de Buenos Aires","ror":"https://ror.org/0081fs513","country_code":"AR","type":"education","lineage":["https://openalex.org/I24354313"]},{"id":"https://openalex.org/I4210119967","display_name":"Hospital de Cl\u00ednicas \"Jos\u00e9 de San Mart\u00edn\"","ror":"https://ror.org/02hbrab76","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210119967"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Mariano Duarte","raw_affiliation_strings":["Laboratorio de Hipertensi\u00f3n, Divisi\u00f3n de Cardiolog\u00eda, Hospital de Cl\u00ednicas \"Jos\u00e9 de San Mart\u00edn\", Facultad de Medicina Universidad de Buenos Aires  Buenos Aires Argentina","Segunda C\u00e1tedra de Fisiolog\u00eda, Facultad de Medicina Universidad de Buenos Aires  Buenos Aires Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratorio de Hipertensi\u00f3n, Divisi\u00f3n de Cardiolog\u00eda, Hospital de Cl\u00ednicas \"Jos\u00e9 de San Mart\u00edn\", Facultad de Medicina Universidad de Buenos Aires  Buenos Aires Argentina","institution_ids":["https://openalex.org/I24354313","https://openalex.org/I4210119967"]},{"raw_affiliation_string":"Segunda C\u00e1tedra de Fisiolog\u00eda, Facultad de Medicina Universidad de Buenos Aires  Buenos Aires Argentina","institution_ids":["https://openalex.org/I24354313"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110758707","display_name":"Liliana Nicolosi","orcid":"https://orcid.org/0000-0001-5337-2893","observed_orcids":["https://orcid.org/0000-0001-5337-2893"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liliana Nicolosi","raw_affiliation_strings":["Divisi\u00f3n de Cardiolog\u00eda Hospital Espa\u00f1ol de Buenos Aires  Buenos Aires Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisi\u00f3n de Cardiolog\u00eda Hospital Espa\u00f1ol de Buenos Aires  Buenos Aires Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002283848","display_name":"Ignacio Fernandez Criado","orcid":"https://orcid.org/0000-0002-7288-3557","observed_orcids":["https://orcid.org/0000-0002-7288-3557"]},"institutions":[{"id":"https://openalex.org/I24354313","display_name":"Universidad de Buenos Aires","ror":"https://ror.org/0081fs513","country_code":"AR","type":"education","lineage":["https://openalex.org/I24354313"]},{"id":"https://openalex.org/I4210119967","display_name":"Hospital de Cl\u00ednicas \"Jos\u00e9 de San Mart\u00edn\"","ror":"https://ror.org/02hbrab76","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210119967"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Fernandez Criado Ignacio","raw_affiliation_strings":["Secci\u00f3n de Tecnolog\u00eda Educativa e Inform\u00e1tica M\u00e9dica, Hospital de Cl\u00ednicas \"Jos\u00e9 de San Mart\u00edn\", Facultad de Medicina Universidad de Buenos Aires  Buenos Aires Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secci\u00f3n de Tecnolog\u00eda Educativa e Inform\u00e1tica M\u00e9dica, Hospital de Cl\u00ednicas \"Jos\u00e9 de San Mart\u00edn\", Facultad de Medicina Universidad de Buenos Aires  Buenos Aires Argentina","institution_ids":["https://openalex.org/I24354313","https://openalex.org/I4210119967"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061408580","display_name":"Mar\u00eda Victoria Salgado","orcid":"https://orcid.org/0000-0003-3449-9703","observed_orcids":["https://orcid.org/0000-0003-3449-9703"]},"institutions":[{"id":"https://openalex.org/I4210150950","display_name":"Center for the Study of State and Society","ror":"https://ror.org/04w908n49","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210150950"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Victoria Salgado","raw_affiliation_strings":["Centro de Estudios de Estado y Sociedad, Ciudad Aut\u00f3noma de Buenos Aires  Buenos Aires Argentina","Servicio de Medicina Familiar, Hospital de Alta Complejidad El Calafate SAMIC, Santa Cruz, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Estudios de Estado y Sociedad, Ciudad Aut\u00f3noma de Buenos Aires  Buenos Aires Argentina","institution_ids":["https://openalex.org/I4210150950"]},{"raw_affiliation_string":"Servicio de Medicina Familiar, Hospital de Alta Complejidad El Calafate SAMIC, Santa Cruz, Argentina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085194358","display_name":"H\u00e9ctor Miguel Vetulli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147699","display_name":"Sanatorio Otamendi y Miroli","ror":"https://ror.org/051pzdg24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210147699"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"H\u00e9ctor Vetulli","raw_affiliation_strings":["Servicio de Electrofisiolog\u00eda Card\u00edaca, Arritmias y Marcapasos, Sanatorio Otamendi y Miroli, Ciudad Aut\u00f3noma de Buenos Aires  Buenos Aires Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Electrofisiolog\u00eda Card\u00edaca, Arritmias y Marcapasos, Sanatorio Otamendi y Miroli, Ciudad Aut\u00f3noma de Buenos Aires  Buenos Aires Argentina","institution_ids":["https://openalex.org/I4210147699"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5044696774"],"corresponding_institution_ids":[],"apc_list":{"value":3850,"currency":"USD","value_usd":3850},"apc_paid":{"value":3850,"currency":"USD","value_usd":3850},"fwci":1.8392,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.8685153,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"11","issue":"2","first_page":"e01083","last_page":"e01083"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6610999703407288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6610999703407288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.31690001487731934,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":0.9570000171661377},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9010000228881836},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ace2","display_name":"ACE2","score":0.7160000205039978},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8370000123977661},{"id":"https://openalex.org/keywords/mortality-reduction","display_name":"mortality reduction","score":0.6439999938011169},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.5009999871253967},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.49300000071525574},{"id":"https://openalex.org/keywords/pharmacological-properties","display_name":"pharmacological properties","score":0.3659999966621399},{"id":"https://openalex.org/keywords/clinical-trial-comparison","display_name":"clinical trial comparison","score":0.3619999885559082},{"id":"https://openalex.org/keywords/europe","display_name":"Europe","score":0.37700000405311584},{"id":"https://openalex.org/keywords/south-america","display_name":"South America","score":0.34299999475479126}],"concepts":[{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.8701387643814087},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.8187383413314819},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7436302900314331},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6751131415367126},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5296463966369629},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4987003803253174},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.369568794965744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.347555935382843},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.19272148609161377},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.08761939406394958},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.06401804089546204},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077333","descriptor_name":"Telmisartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/prp2.1083","doi":"https://doi.org/10.1002/prp2.1083","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.1083","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.1083","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10086312","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10086312","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10086312/pdf/PRP2-11-e01083.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacol Res Perspect","raw_type":"Text"},{"id":"pmid:37038324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37038324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology research & perspectives","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:236c8e2e27c34ebcac15c3ddbb781125","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/236c8e2e27c34ebcac15c3ddbb781125","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology Research & Perspectives, Vol 11, Iss 2, Pp n/a-n/a (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/prp2.1083","doi":"https://doi.org/10.1002/prp2.1083","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.1083","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.1083","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4363672583.pdf","grobid_xml":"https://content.openalex.org/works/W4363672583.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1588262205","https://openalex.org/W2014231321","https://openalex.org/W2047852384","https://openalex.org/W2081433798","https://openalex.org/W2090314376","https://openalex.org/W2097957153","https://openalex.org/W2104620139","https://openalex.org/W2119678013","https://openalex.org/W2137965090","https://openalex.org/W2149884828","https://openalex.org/W2893443076","https://openalex.org/W3009723094","https://openalex.org/W3016572296","https://openalex.org/W3017331996","https://openalex.org/W3022288447","https://openalex.org/W3031053977","https://openalex.org/W3043851305","https://openalex.org/W3094330554","https://openalex.org/W3109866843","https://openalex.org/W3141893624","https://openalex.org/W3174069355","https://openalex.org/W3175301529","https://openalex.org/W3178245659","https://openalex.org/W4200378616","https://openalex.org/W4205243058","https://openalex.org/W4220769600","https://openalex.org/W4281716653","https://openalex.org/W4283017366","https://openalex.org/W4283070932","https://openalex.org/W4293207090","https://openalex.org/W4295066661","https://openalex.org/W4309515605","https://openalex.org/W4323353055"],"related_works":["https://openalex.org/W4295066661","https://openalex.org/W3022288447","https://openalex.org/W3175301529","https://openalex.org/W4386660257","https://openalex.org/W4388091223","https://openalex.org/W4416952427","https://openalex.org/W4400493096","https://openalex.org/W3165335299","https://openalex.org/W3086357940","https://openalex.org/W3171645706"],"abstract_inverted_index":{"At":[0],"the":[1,4,26,29,32,38,45,49,58,78,86,124,139,150,154,164,167,188,204,219,259,287,294,316,326],"beginning":[2],"of":[3,28,31,40,51,67,80,109,141,166,173,221,231,261,273,296,299,312,329],"COVID-19":[5,144,243,303],"pandemic,":[6],"Gurwitz,":[7],"1":[8],"taking":[9],"into":[10],"account":[11],"that":[12,134],"SARS-CoV-2":[13,330],"virus":[14],"enters":[15],"cells":[16],"after":[17,127,226,258],"binding":[18],"to":[19,44,48,246,322,337],"ACE2":[20],"(Angiotensin":[21],"Converting":[22],"Enzyme":[23],"2),":[24],"proposed":[25],"hypothesis":[27,46],"involvement":[30],"RAS":[33],"(Renin":[34],"Angiotensin":[35],"System)":[36],"in":[37,90,102,198,218,229,239,281,302,309],"pathophysiology":[39],"this":[41],"disease.Our":[42],"adherence":[43],"led":[47],"design":[50],"a":[52,65,71,93,271,289],"clinical":[53,94],"trial":[54,95],"selecting":[55],"telmisartan":[56,210,300],"among":[57],"angiotensin":[59,205],"AT1":[60,207],"receptor":[61,208],"blockers":[62],"(ARBs)":[63],"at":[64,175,223,270],"dose":[66,272],"80":[68,232],"mg":[69,111,233,275,334],"twice":[70,113,276],"day,":[72],"orally,":[73],"for":[74,77,115,138,153,235,278],"14":[75,236],"days,":[76],"treatment":[79,140,301],"hospitalized":[81,103,240,282],"patients":[82,104,142,241,283],"with":[83,96,105,143,187,242,284],"COVID-19.2":[84],"On":[85,286],"contrary,":[87,288],"also":[88],"starting":[89],"April":[91],"2020,":[92,321],"losartan,":[97],"another":[98],"ARB,":[99],"was":[100,306,331],"designed":[101],"COVID-19,":[106],"administering":[107],"doses":[108,230],"50":[110,274],"orally":[112],"daily":[114,277],"10":[116,279],"days":[117,225,237,257,280],"(NCT04312009).Recently,":[118],"Liu":[119],"et":[120],"al.":[121],"3":[122],"published":[123],"results":[125,295],"obtained":[126],"analyzing":[128],"54":[129],"randomized":[130],"controlled":[131],"trials":[132],"(RCTs)":[133],"compared":[135],"13":[136,324],"drugs":[137,151,168,193],"against":[145],"placebo":[146],"or":[147],"standard":[148],"care.Among":[149],"selected":[152],"analysis,":[155],"they":[156],"included":[157],"two":[158],"ARBs,":[159],"telmisartan,":[160],"and":[161,185,238,251],"losartan.To":[162],"evaluate":[163],"efficacy":[165,197,269],"included,":[169],"covered":[170],"all":[171,313],"causes":[172],"mortality":[174,222],"5-8,":[176],"14/15,":[177],"21-,":[178],"25-,":[179],"28/30,":[180],"35-,":[181],"45-,":[182],"60-,":[183],"70,":[184],"90-days.Compared":[186],"control":[189],"group,":[190],"only":[191],"four":[192,202],"showed":[194,214],"statistically":[195],"significant":[196],"reducing":[199],"mortality.Among":[200],"these":[201],"drugs,":[203],"II":[206],"blocker":[209],"stands":[211],"out,":[212],"which":[213],"an":[215,247,297],"81%":[216],"reduction":[217],"risk":[220],"30":[224],"oral":[227,268],"administration":[228],"twice/day":[234],"not":[244,266],"admitted":[245],"intensive":[248],"care":[249],"unit":[250],"from":[252,318],"no":[253],"more":[254],"than":[255],"4":[256],"onset":[260],"symptoms.4":[262],"Conversely,":[263],"losartan":[264],"did":[265],"show":[267],"COVID-19.5":[285],"recent":[290],"article":[291],"6":[292],"reported":[293],"RCT":[298],"patients.This":[304],"study":[305],"conducted":[307],"largely":[308],"India":[310],"(99%":[311],"subjects)":[314],"during":[315],"period":[317],"May":[319],"3,":[320],"November":[323],"when":[325],"delta":[327],"variant":[328],"present.Telmisartan":[332],"(40":[333],"daily)":[335],"failed":[336],"reduce":[338],"mortality.":[339]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-04-11T00:00:00"}